Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors - Shah, Chintan; Gong, Yan; Szady, Anita; Sun, Qian; Pepine, Carl J.; Langaee, Taimour; Lucas, Alexandra R.; Moreb, Jan S. (Cardiovascular toxicology, 2018)
Keywords: Adult; Aged; Aged, 80 and over; Anthracycline; Anthracyclines; Antineoplastic Agents - adverse effects; Biomedical and Life Sciences; Biomedicine; Blood cancer; Cancer; Cancer patients; Cancer therapies; Cardiology; Cardiotoxicity; Cardiovascular diseases; Carfilzomib; Chemotherapy; Female; Health aspects; Heart diseases; Heart Diseases - chemically induced; Heart Diseases - diagnosis; Heart Diseases - mortality; Heart Diseases - physiopathology; Hematologic Neoplasms - drug therapy; Hematologic Neoplasms - immunology; Hematologic Neoplasms - metabolism; Hematologic Neoplasms - mortality; Humans; Immunomodulation; Karnofsky Performance Status; Male; Medical research; Medicine, Experimental; Middle Aged; Molecular Targeted Therapy - adverse effects; Monoclonal antibodies; Multivariate analysis; Pharmacology/Toxicology; Proteasome inhibitors; Protein-tyrosine kinase; Pulmonary Embolism - complications; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thrombosis - complications; Targeted therapy; Hematologic malignancies; Cardiotoxicity